| # | Drug | Count |
|---|---|---|
| 0 | FINGOLIMOD HCL | 12 |
| 1 | LEVETIRACETAM | 11 |
| 2 | LEVETIRACETAM IN SODIUM CHLORIDE | 11 |
| 3 | LEVETIRACETAM INJECTION | 11 |
| 4 | LEVETIRACETAM ORAL | 11 |
| 5 | BRIVARACETAM | 8 |
| 6 | BRIVARACETAM INJECTION | 8 |
| 7 | FINGOLIMOD | 3 |
| 8 | FINGOLIMOD HYDROCHLORIDE | 3 |
| 9 | INTERFERON BETA-1A | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRIVARACETAM | 8 | 0.0009 |
| 1 | FINGOLIMOD HYDROCHLORIDE | 3 | 0.0006 |
| 2 | LEVETIRACETAM ORAL | 11 | 0.0001 |
| 3 | LEVETIRACETAM INJECTION | 11 | 0.0001 |
| 4 | FINGOLIMOD HCL | 12 | 0.0001 |
| 5 | OZANIMOD HYDROCHLORIDE | 1 | 0.0001 |
| 6 | LEVETIRACETAM | 11 | 0.0001 |
| 7 | GOLIMUMAB | 1 | 0.0001 |
| 8 | INTERFERON BETA-1A | 3 | 0.0000 |
| 9 | DALFAMPRIDINE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 3 | 0.0002 |
| 1 | Interferon beta [EPC] | 3 | 0.0000 |
| 2 | Potassium Channel Blocker [EPC] | 1 | 0.0000 |
| 3 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 1 | 0.0000 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |
| 7 | Corticosteroid [EPC] | 1 | 0.0000 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |